| Filed On | Filing |
|---|---|
| 06 Oct 2026 |
Form 4: Singer Andrew E., Director
Granted 14,000 Stock Option (Right to Buy) |
| 06 Oct 2026 |
Form 3: Singer Andrew E., Director
No securities owned |
| 06 Oct 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
On September 30, 2026, Kyntra Bio, Inc. (the “Company” or “Kyntra Bio”) received a determination letter (“Determination”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company... |
| 01 Oct 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
SAN FRANCISCO, October 1, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB) today announced the appointment of Andrew E. Singer, MBA to its Board of Directors as an independent director and member of the Audit Committee effective Octobe... |
| 09 Sep 2026 |
Form 4: DeLucia David, Chief Financial Officer
Gave up 22 shares to cover exercise price or tax ($188) |
| 09 Sep 2026 |
Form 4: Wettig Thane, Director
Gave up 209 shares to cover exercise price or tax ($1.79K) |
| 31 Aug 2026 | 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | 10-Q |
| 13 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 17 Jun 2026 |
Form 4: Ho Maykin, Director
Granted 7,000 Stock Option (Right to Buy) |
| 17 Jun 2026 |
Form 4: Edwards Jeffrey L, Director
Granted 7,000 Stock Option (Right to Buy) |
| 17 Jun 2026 |
Form 4: Kauffman Michael, Director
Granted 7,000 Stock Option (Right to Buy) |
| 17 Jun 2026 |
Form 4: Schoeneck James A, Director
Granted 7,000 Stock Option (Right to Buy) |
| 16 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 09 Jun 2026 |
Form 4: DeLucia David, Chief Financial Officer
Gave up 52 shares to cover exercise price or tax ($349) |
| 09 Jun 2026 |
Form 4: Wettig Thane, Director
Gave up 198 shares to cover exercise price or tax ($1.33K) |
| 09 Jun 2026 | 8-K: Other Events |
| 19 May 2026 |
Form 4/A: Wettig Thane, Director
Bought 2,800 shares ($19.9K) |
| 18 May 2026 |
Form 4: Wettig Thane, Director
Disposed of 2,800 shares (Open Market Purchase) ($19.9K) |
Loading...
